Stockhead on MSN

Rhythm secures Australian lab partner to scale geneType testing

Rhythm establishes a strategic partnership with the Australian Genome Research Facility to establish domestic, ...
Seeking Alpha

Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome

BOSTON, April 24, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living ...
Stockhead on MSN

Rhythm Biosciences partners with CancerIQ to accelerate geneType US adoption

Rhythm Biosciences has inked a strategic partnership with leading US-based digital healthcare technology platform CancerIQ, ...
Seeking Alpha

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses On Commercial Readiness For Acquired Hypothalamic Obesity Event Call (Transcript)

Good morning, everybody. Thank you for joining us today. I'm Dave Connolly, IR here at Rhythm Pharmaceuticals. Before we begin the speaking program, I'll just remind you that this event may include ...